The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer

Prognostic comparison of the proliferation markers mitotic activity index, phosphohistone H3, Ki67, steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T 1-2 N 0 M 0 breast cancer

(2013) Einar Gudlaugsson et al.   POLISH JOURNAL OF PATHOLOGY

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen

(2012) A. Prat et al.   ANNALS OF ONCOLOGY

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer

(2012) Einar Gudlaugsson et al.   HISTOPATHOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer

(2011) Carina Strand et al.   BREAST CANCER RESEARCH AND TREATMENT

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

(2010) Anthoula Koliadi et al.   ACTA ONCOLOGICA

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant!

(2010) Tone Hoel Lende et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

(2009) Einar Gudlaugsson et al.   BREAST CANCER RESEARCH AND TREATMENT

Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer

(2009) C. Ahlin et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer

(2009) Marie Klintman et al.   MODERN PATHOLOGY

Evaluation of 5 Different Labeled Polymer Immunohistochemical Detection Systems

(2009) Ivar Skaland et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age

(2008) Ivar Skaland et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic differences of World Health Organization–assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years

(2008) Ivar Skaland et al.   HUMAN PATHOLOGY